カテゴリー： 世界, 医療/バイオ, LP Information

世界のホスホジエステラーゼ-5阻害剤市場予測 2023年-2029年

【英語タイトル】Global Phosphodiesterase-5 Inhibitor Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07604）・商品コード：LP23DC07604
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のホスホジエステラーゼ-5阻害剤市場」は、過去の販売実績から2022年の世界のホスホジエステラーゼ-5阻害剤の総販売量を検討し、2023年から2029年の予測されるホスホジエステラーゼ-5阻害剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のホスホジエステラーゼ-5阻害剤の市場規模を掲載し、XXX百万米ドル規模の世界のホスホジエステラーゼ-5阻害剤市場の詳細な分析を提供します。本インサイトレポートは、世界のホスホジエステラーゼ-5阻害剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のホスホジエステラーゼ-5阻害剤市場における各社の独自のポジションをより深く理解するために、ホスホジエステラーゼ-5阻害剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のホスホジエステラーゼ-5阻害剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ホスホジエステラーゼ-5阻害剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ホスホジエステラーゼ-5阻害剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ホスホジエステラーゼ-5阻害剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ホスホジエステラーゼ-5阻害剤の世界主要メーカーとしては、Pfizer、 Eli Lilly、 Baye、 Dong-A Pharm、 Torrent Pharmaceuticals、 GSK、 Abbott Laboratories、 Teva Pharmaceuticals、 Hetero Drugs、 Zydus Cadilaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のホスホジエステラーゼ-5阻害剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではホスホジエステラーゼ-5阻害剤市場をセグメンテーションし、種類別 (経口錠剤、経口液剤)、用途別 (病院、製薬会社、研究所、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：経口錠剤、経口液剤

・用途別区分：病院、製薬会社、研究所、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のホスホジエステラーゼ-5阻害剤市場の10年間の市場状況・展望は？
・世界および地域別に見たホスホジエステラーゼ-5阻害剤市場成長の要因は何か？
・ホスホジエステラーゼ-5阻害剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・ホスホジエステラーゼ-5阻害剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ホスホジエステラーゼ-5阻害剤の年間販売量2018-2029、地域別現状・将来分析
・ホスホジエステラーゼ-5阻害剤の種類別セグメント：経口錠剤、経口液剤
・ホスホジエステラーゼ-5阻害剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ホスホジエステラーゼ-5阻害剤の用途別セグメント：病院、製薬会社、研究所、診療所、その他
・ホスホジエステラーゼ-5阻害剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のホスホジエステラーゼ-5阻害剤市場
・企業別のグローバルホスホジエステラーゼ-5阻害剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のホスホジエステラーゼ-5阻害剤の年間売上：2018-2023年の売上、市場シェア
・企業別のホスホジエステラーゼ-5阻害剤販売価格
・主要企業のホスホジエステラーゼ-5阻害剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ホスホジエステラーゼ-5阻害剤の地域別レビュー
・地域別のホスホジエステラーゼ-5阻害剤市場規模2018-2023：年間販売量、売上
・主要国別のホスホジエステラーゼ-5阻害剤市場規模2018-2023：年間販売量、売上
・南北アメリカのホスホジエステラーゼ-5阻害剤販売の成長
・アジア太平洋のホスホジエステラーゼ-5阻害剤販売の成長
・ヨーロッパのホスホジエステラーゼ-5阻害剤販売の成長
・中東・アフリカのホスホジエステラーゼ-5阻害剤販売の成長

南北アメリカ市場
・南北アメリカの国別のホスホジエステラーゼ-5阻害剤販売量、売上（2018-2023）
・南北アメリカのホスホジエステラーゼ-5阻害剤の種類別販売量
・南北アメリカのホスホジエステラーゼ-5阻害剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のホスホジエステラーゼ-5阻害剤販売量、売上（2018-2023）
・アジア太平洋のホスホジエステラーゼ-5阻害剤の種類別販売量
・アジア太平洋のホスホジエステラーゼ-5阻害剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のホスホジエステラーゼ-5阻害剤販売量、売上（2018-2023）
・ヨーロッパのホスホジエステラーゼ-5阻害剤の種類別販売量
・ヨーロッパのホスホジエステラーゼ-5阻害剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のホスホジエステラーゼ-5阻害剤販売量、売上（2018-2023）
・中東・アフリカのホスホジエステラーゼ-5阻害剤の種類別販売量
・中東・アフリカのホスホジエステラーゼ-5阻害剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ホスホジエステラーゼ-5阻害剤の製造コスト構造分析
・ホスホジエステラーゼ-5阻害剤の製造プロセス分析
・ホスホジエステラーゼ-5阻害剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ホスホジエステラーゼ-5阻害剤の主要なグローバル販売業者
・ホスホジエステラーゼ-5阻害剤の主要なグローバル顧客

地域別のホスホジエステラーゼ-5阻害剤市場予測レビュー
・地域別のホスホジエステラーゼ-5阻害剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ホスホジエステラーゼ-5阻害剤の種類別市場規模予測
・ホスホジエステラーゼ-5阻害剤の用途別市場規模予測

主要企業分析
Pfizer、 Eli Lilly、 Baye、 Dong-A Pharm、 Torrent Pharmaceuticals、 GSK、 Abbott Laboratories、 Teva Pharmaceuticals、 Hetero Drugs、 Zydus Cadila
・企業情報
・ホスホジエステラーゼ-5阻害剤製品
・ホスホジエステラーゼ-5阻害剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Phosphodiesterase-5 Inhibitor market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Phosphodiesterase-5 Inhibitor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Phosphodiesterase-5 Inhibitor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Phosphodiesterase-5 Inhibitor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Phosphodiesterase-5 Inhibitor players cover Pfizer, Eli Lilly, Baye, Dong-A Pharm, Torrent Pharmaceuticals, GSK, Abbott Laboratories, Teva Pharmaceuticals and Hetero Drugs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Phosphodiesterase-5 Inhibitor Industry Forecast” looks at past sales and reviews total world Phosphodiesterase-5 Inhibitor sales in 2022, providing a comprehensive analysis by region and market sector of projected Phosphodiesterase-5 Inhibitor sales for 2023 through 2029. With Phosphodiesterase-5 Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phosphodiesterase-5 Inhibitor industry.
This Insight Report provides a comprehensive analysis of the global Phosphodiesterase-5 Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phosphodiesterase-5 Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phosphodiesterase-5 Inhibitor market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phosphodiesterase-5 Inhibitor and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phosphodiesterase-5 Inhibitor.
This report presents a comprehensive overview, market shares, and growth opportunities of Phosphodiesterase-5 Inhibitor market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Oral Tablet
Oral Liquid
Segmentation by application
Hospital
Pharmaceutical Company
Laboratory
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
Eli Lilly
Baye
Dong-A Pharm
Torrent Pharmaceuticals
GSK
Abbott Laboratories
Teva Pharmaceuticals
Hetero Drugs
Zydus Cadila
Key Questions Addressed in this Report
What is the 10-year outlook for the global Phosphodiesterase-5 Inhibitor market?
What factors are driving Phosphodiesterase-5 Inhibitor market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Phosphodiesterase-5 Inhibitor market opportunities vary by end market size?
How does Phosphodiesterase-5 Inhibitor break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phosphodiesterase-5 Inhibitor Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Phosphodiesterase-5 Inhibitor by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Phosphodiesterase-5 Inhibitor by Country/Region, 2018, 2022 & 2029
2.2 Phosphodiesterase-5 Inhibitor Segment by Type
2.2.1 Oral Tablet
2.2.2 Oral Liquid
2.3 Phosphodiesterase-5 Inhibitor Sales by Type
2.3.1 Global Phosphodiesterase-5 Inhibitor Sales Market Share by Type (2018-2023)
2.3.2 Global Phosphodiesterase-5 Inhibitor Revenue and Market Share by Type (2018-2023)
2.3.3 Global Phosphodiesterase-5 Inhibitor Sale Price by Type (2018-2023)
2.4 Phosphodiesterase-5 Inhibitor Segment by Application
2.4.1 Hospital
2.4.2 Pharmaceutical Company
2.4.3 Laboratory
2.4.4 Clinic
2.4.5 Others
2.5 Phosphodiesterase-5 Inhibitor Sales by Application
2.5.1 Global Phosphodiesterase-5 Inhibitor Sale Market Share by Application (2018-2023)
2.5.2 Global Phosphodiesterase-5 Inhibitor Revenue and Market Share by Application (2018-2023)
2.5.3 Global Phosphodiesterase-5 Inhibitor Sale Price by Application (2018-2023)
3 Global Phosphodiesterase-5 Inhibitor by Company
3.1 Global Phosphodiesterase-5 Inhibitor Breakdown Data by Company
3.1.1 Global Phosphodiesterase-5 Inhibitor Annual Sales by Company (2018-2023)
3.1.2 Global Phosphodiesterase-5 Inhibitor Sales Market Share by Company (2018-2023)
3.2 Global Phosphodiesterase-5 Inhibitor Annual Revenue by Company (2018-2023)
3.2.1 Global Phosphodiesterase-5 Inhibitor Revenue by Company (2018-2023)
3.2.2 Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Company (2018-2023)
3.3 Global Phosphodiesterase-5 Inhibitor Sale Price by Company
3.4 Key Manufacturers Phosphodiesterase-5 Inhibitor Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Phosphodiesterase-5 Inhibitor Product Location Distribution
3.4.2 Players Phosphodiesterase-5 Inhibitor Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Phosphodiesterase-5 Inhibitor by Geographic Region
4.1 World Historic Phosphodiesterase-5 Inhibitor Market Size by Geographic Region (2018-2023)
4.1.1 Global Phosphodiesterase-5 Inhibitor Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Phosphodiesterase-5 Inhibitor Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Phosphodiesterase-5 Inhibitor Market Size by Country/Region (2018-2023)
4.2.1 Global Phosphodiesterase-5 Inhibitor Annual Sales by Country/Region (2018-2023)
4.2.2 Global Phosphodiesterase-5 Inhibitor Annual Revenue by Country/Region (2018-2023)
4.3 Americas Phosphodiesterase-5 Inhibitor Sales Growth
4.4 APAC Phosphodiesterase-5 Inhibitor Sales Growth
4.5 Europe Phosphodiesterase-5 Inhibitor Sales Growth
4.6 Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Growth
5 Americas
5.1 Americas Phosphodiesterase-5 Inhibitor Sales by Country
5.1.1 Americas Phosphodiesterase-5 Inhibitor Sales by Country (2018-2023)
5.1.2 Americas Phosphodiesterase-5 Inhibitor Revenue by Country (2018-2023)
5.2 Americas Phosphodiesterase-5 Inhibitor Sales by Type
5.3 Americas Phosphodiesterase-5 Inhibitor Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phosphodiesterase-5 Inhibitor Sales by Region
6.1.1 APAC Phosphodiesterase-5 Inhibitor Sales by Region (2018-2023)
6.1.2 APAC Phosphodiesterase-5 Inhibitor Revenue by Region (2018-2023)
6.2 APAC Phosphodiesterase-5 Inhibitor Sales by Type
6.3 APAC Phosphodiesterase-5 Inhibitor Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Phosphodiesterase-5 Inhibitor by Country
7.1.1 Europe Phosphodiesterase-5 Inhibitor Sales by Country (2018-2023)
7.1.2 Europe Phosphodiesterase-5 Inhibitor Revenue by Country (2018-2023)
7.2 Europe Phosphodiesterase-5 Inhibitor Sales by Type
7.3 Europe Phosphodiesterase-5 Inhibitor Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Phosphodiesterase-5 Inhibitor by Country
8.1.1 Middle East & Africa Phosphodiesterase-5 Inhibitor Sales by Country (2018-2023)
8.1.2 Middle East & Africa Phosphodiesterase-5 Inhibitor Revenue by Country (2018-2023)
8.2 Middle East & Africa Phosphodiesterase-5 Inhibitor Sales by Type
8.3 Middle East & Africa Phosphodiesterase-5 Inhibitor Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Phosphodiesterase-5 Inhibitor
10.3 Manufacturing Process Analysis of Phosphodiesterase-5 Inhibitor
10.4 Industry Chain Structure of Phosphodiesterase-5 Inhibitor
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Phosphodiesterase-5 Inhibitor Distributors
11.3 Phosphodiesterase-5 Inhibitor Customer
12 World Forecast Review for Phosphodiesterase-5 Inhibitor by Geographic Region
12.1 Global Phosphodiesterase-5 Inhibitor Market Size Forecast by Region
12.1.1 Global Phosphodiesterase-5 Inhibitor Forecast by Region (2024-2029)
12.1.2 Global Phosphodiesterase-5 Inhibitor Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Phosphodiesterase-5 Inhibitor Forecast by Type
12.7 Global Phosphodiesterase-5 Inhibitor Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.1.3 Pfizer Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.2.3 Eli Lilly Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Baye
13.3.1 Baye Company Information
13.3.2 Baye Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.3.3 Baye Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Baye Main Business Overview
13.3.5 Baye Latest Developments
13.4 Dong-A Pharm
13.4.1 Dong-A Pharm Company Information
13.4.2 Dong-A Pharm Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.4.3 Dong-A Pharm Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dong-A Pharm Main Business Overview
13.4.5 Dong-A Pharm Latest Developments
13.5 Torrent Pharmaceuticals
13.5.1 Torrent Pharmaceuticals Company Information
13.5.2 Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.5.3 Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Torrent Pharmaceuticals Main Business Overview
13.5.5 Torrent Pharmaceuticals Latest Developments
13.6 GSK
13.6.1 GSK Company Information
13.6.2 GSK Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.6.3 GSK Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GSK Main Business Overview
13.6.5 GSK Latest Developments
13.7 Abbott Laboratories
13.7.1 Abbott Laboratories Company Information
13.7.2 Abbott Laboratories Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.7.3 Abbott Laboratories Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Laboratories Main Business Overview
13.7.5 Abbott Laboratories Latest Developments
13.8 Teva Pharmaceuticals
13.8.1 Teva Pharmaceuticals Company Information
13.8.2 Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.8.3 Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Teva Pharmaceuticals Main Business Overview
13.8.5 Teva Pharmaceuticals Latest Developments
13.9 Hetero Drugs
13.9.1 Hetero Drugs Company Information
13.9.2 Hetero Drugs Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.9.3 Hetero Drugs Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hetero Drugs Main Business Overview
13.9.5 Hetero Drugs Latest Developments
13.10 Zydus Cadila
13.10.1 Zydus Cadila Company Information
13.10.2 Zydus Cadila Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
13.10.3 Zydus Cadila Phosphodiesterase-5 Inhibitor Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zydus Cadila Main Business Overview
13.10.5 Zydus Cadila Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Phosphodiesterase-5 Inhibitor Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Phosphodiesterase-5 Inhibitor Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral Tablet
Table 4. Major Players of Oral Liquid
Table 5. Global Phosphodiesterase-5 Inhibitor Sales by Type (2018-2023) & (K Units)
Table 6. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Type (2018-2023)
Table 7. Global Phosphodiesterase-5 Inhibitor Revenue by Type (2018-2023) & ($ million)
Table 8. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Type (2018-2023)
Table 9. Global Phosphodiesterase-5 Inhibitor Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Phosphodiesterase-5 Inhibitor Sales by Application (2018-2023) & (K Units)
Table 11. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Application (2018-2023)
Table 12. Global Phosphodiesterase-5 Inhibitor Revenue by Application (2018-2023)
Table 13. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Application (2018-2023)
Table 14. Global Phosphodiesterase-5 Inhibitor Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Phosphodiesterase-5 Inhibitor Sales by Company (2018-2023) & (K Units)
Table 16. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Company (2018-2023)
Table 17. Global Phosphodiesterase-5 Inhibitor Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Company (2018-2023)
Table 19. Global Phosphodiesterase-5 Inhibitor Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Phosphodiesterase-5 Inhibitor Producing Area Distribution and Sales Area
Table 21. Players Phosphodiesterase-5 Inhibitor Products Offered
Table 22. Phosphodiesterase-5 Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Phosphodiesterase-5 Inhibitor Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Phosphodiesterase-5 Inhibitor Sales Market Share Geographic Region (2018-2023)
Table 27. Global Phosphodiesterase-5 Inhibitor Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Phosphodiesterase-5 Inhibitor Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Country/Region (2018-2023)
Table 31. Global Phosphodiesterase-5 Inhibitor Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Phosphodiesterase-5 Inhibitor Sales by Country (2018-2023) & (K Units)
Table 34. Americas Phosphodiesterase-5 Inhibitor Sales Market Share by Country (2018-2023)
Table 35. Americas Phosphodiesterase-5 Inhibitor Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Phosphodiesterase-5 Inhibitor Revenue Market Share by Country (2018-2023)
Table 37. Americas Phosphodiesterase-5 Inhibitor Sales by Type (2018-2023) & (K Units)
Table 38. Americas Phosphodiesterase-5 Inhibitor Sales by Application (2018-2023) & (K Units)
Table 39. APAC Phosphodiesterase-5 Inhibitor Sales by Region (2018-2023) & (K Units)
Table 40. APAC Phosphodiesterase-5 Inhibitor Sales Market Share by Region (2018-2023)
Table 41. APAC Phosphodiesterase-5 Inhibitor Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Phosphodiesterase-5 Inhibitor Revenue Market Share by Region (2018-2023)
Table 43. APAC Phosphodiesterase-5 Inhibitor Sales by Type (2018-2023) & (K Units)
Table 44. APAC Phosphodiesterase-5 Inhibitor Sales by Application (2018-2023) & (K Units)
Table 45. Europe Phosphodiesterase-5 Inhibitor Sales by Country (2018-2023) & (K Units)
Table 46. Europe Phosphodiesterase-5 Inhibitor Sales Market Share by Country (2018-2023)
Table 47. Europe Phosphodiesterase-5 Inhibitor Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Phosphodiesterase-5 Inhibitor Revenue Market Share by Country (2018-2023)
Table 49. Europe Phosphodiesterase-5 Inhibitor Sales by Type (2018-2023) & (K Units)
Table 50. Europe Phosphodiesterase-5 Inhibitor Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Phosphodiesterase-5 Inhibitor Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Phosphodiesterase-5 Inhibitor Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Phosphodiesterase-5 Inhibitor
Table 58. Key Market Challenges & Risks of Phosphodiesterase-5 Inhibitor
Table 59. Key Industry Trends of Phosphodiesterase-5 Inhibitor
Table 60. Phosphodiesterase-5 Inhibitor Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Phosphodiesterase-5 Inhibitor Distributors List
Table 63. Phosphodiesterase-5 Inhibitor Customer List
Table 64. Global Phosphodiesterase-5 Inhibitor Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Phosphodiesterase-5 Inhibitor Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Phosphodiesterase-5 Inhibitor Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Phosphodiesterase-5 Inhibitor Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Phosphodiesterase-5 Inhibitor Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Phosphodiesterase-5 Inhibitor Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Phosphodiesterase-5 Inhibitor Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Phosphodiesterase-5 Inhibitor Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Phosphodiesterase-5 Inhibitor Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Phosphodiesterase-5 Inhibitor Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Phosphodiesterase-5 Inhibitor Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Phosphodiesterase-5 Inhibitor Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Phosphodiesterase-5 Inhibitor Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 80. Pfizer Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Eli Lilly Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 85. Eli Lilly Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. Baye Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 89. Baye Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 90. Baye Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Baye Main Business
Table 92. Baye Latest Developments
Table 93. Dong-A Pharm Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 94. Dong-A Pharm Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 95. Dong-A Pharm Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Dong-A Pharm Main Business
Table 97. Dong-A Pharm Latest Developments
Table 98. Torrent Pharmaceuticals Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 99. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 100. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Torrent Pharmaceuticals Main Business
Table 102. Torrent Pharmaceuticals Latest Developments
Table 103. GSK Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 104. GSK Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 105. GSK Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. GSK Main Business
Table 107. GSK Latest Developments
Table 108. Abbott Laboratories Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Laboratories Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 110. Abbott Laboratories Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Abbott Laboratories Main Business
Table 112. Abbott Laboratories Latest Developments
Table 113. Teva Pharmaceuticals Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 115. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Teva Pharmaceuticals Main Business
Table 117. Teva Pharmaceuticals Latest Developments
Table 118. Hetero Drugs Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 119. Hetero Drugs Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 120. Hetero Drugs Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Hetero Drugs Main Business
Table 122. Hetero Drugs Latest Developments
Table 123. Zydus Cadila Basic Information, Phosphodiesterase-5 Inhibitor Manufacturing Base, Sales Area and Its Competitors
Table 124. Zydus Cadila Phosphodiesterase-5 Inhibitor Product Portfolios and Specifications
Table 125. Zydus Cadila Phosphodiesterase-5 Inhibitor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Zydus Cadila Main Business
Table 127. Zydus Cadila Latest Developments
List of Figures
Figure 1. Picture of Phosphodiesterase-5 Inhibitor
Figure 2. Phosphodiesterase-5 Inhibitor Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Phosphodiesterase-5 Inhibitor Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Phosphodiesterase-5 Inhibitor Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Phosphodiesterase-5 Inhibitor Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral Tablet
Figure 10. Product Picture of Oral Liquid
Figure 11. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Type in 2022
Figure 12. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Type (2018-2023)
Figure 13. Phosphodiesterase-5 Inhibitor Consumed in Hospital
Figure 14. Global Phosphodiesterase-5 Inhibitor Market: Hospital (2018-2023) & (K Units)
Figure 15. Phosphodiesterase-5 Inhibitor Consumed in Pharmaceutical Company
Figure 16. Global Phosphodiesterase-5 Inhibitor Market: Pharmaceutical Company (2018-2023) & (K Units)
Figure 17. Phosphodiesterase-5 Inhibitor Consumed in Laboratory
Figure 18. Global Phosphodiesterase-5 Inhibitor Market: Laboratory (2018-2023) & (K Units)
Figure 19. Phosphodiesterase-5 Inhibitor Consumed in Clinic
Figure 20. Global Phosphodiesterase-5 Inhibitor Market: Clinic (2018-2023) & (K Units)
Figure 21. Phosphodiesterase-5 Inhibitor Consumed in Others
Figure 22. Global Phosphodiesterase-5 Inhibitor Market: Others (2018-2023) & (K Units)
Figure 23. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Application (2022)
Figure 24. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Application in 2022
Figure 25. Phosphodiesterase-5 Inhibitor Sales Market by Company in 2022 (K Units)
Figure 26. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Company in 2022
Figure 27. Phosphodiesterase-5 Inhibitor Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Company in 2022
Figure 29. Global Phosphodiesterase-5 Inhibitor Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Phosphodiesterase-5 Inhibitor Sales 2018-2023 (K Units)
Figure 32. Americas Phosphodiesterase-5 Inhibitor Revenue 2018-2023 ($ Millions)
Figure 33. APAC Phosphodiesterase-5 Inhibitor Sales 2018-2023 (K Units)
Figure 34. APAC Phosphodiesterase-5 Inhibitor Revenue 2018-2023 ($ Millions)
Figure 35. Europe Phosphodiesterase-5 Inhibitor Sales 2018-2023 (K Units)
Figure 36. Europe Phosphodiesterase-5 Inhibitor Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Phosphodiesterase-5 Inhibitor Revenue 2018-2023 ($ Millions)
Figure 39. Americas Phosphodiesterase-5 Inhibitor Sales Market Share by Country in 2022
Figure 40. Americas Phosphodiesterase-5 Inhibitor Revenue Market Share by Country in 2022
Figure 41. Americas Phosphodiesterase-5 Inhibitor Sales Market Share by Type (2018-2023)
Figure 42. Americas Phosphodiesterase-5 Inhibitor Sales Market Share by Application (2018-2023)
Figure 43. United States Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Phosphodiesterase-5 Inhibitor Sales Market Share by Region in 2022
Figure 48. APAC Phosphodiesterase-5 Inhibitor Revenue Market Share by Regions in 2022
Figure 49. APAC Phosphodiesterase-5 Inhibitor Sales Market Share by Type (2018-2023)
Figure 50. APAC Phosphodiesterase-5 Inhibitor Sales Market Share by Application (2018-2023)
Figure 51. China Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Phosphodiesterase-5 Inhibitor Sales Market Share by Country in 2022
Figure 59. Europe Phosphodiesterase-5 Inhibitor Revenue Market Share by Country in 2022
Figure 60. Europe Phosphodiesterase-5 Inhibitor Sales Market Share by Type (2018-2023)
Figure 61. Europe Phosphodiesterase-5 Inhibitor Sales Market Share by Application (2018-2023)
Figure 62. Germany Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Phosphodiesterase-5 Inhibitor Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Phosphodiesterase-5 Inhibitor Sales Market Share by Application (2018-2023)
Figure 71. Egypt Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Phosphodiesterase-5 Inhibitor Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Phosphodiesterase-5 Inhibitor in 2022
Figure 77. Manufacturing Process Analysis of Phosphodiesterase-5 Inhibitor
Figure 78. Industry Chain Structure of Phosphodiesterase-5 Inhibitor
Figure 79. Channels of Distribution
Figure 80. Global Phosphodiesterase-5 Inhibitor Sales Market Forecast by Region (2024-2029)
Figure 81. Global Phosphodiesterase-5 Inhibitor Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Phosphodiesterase-5 Inhibitor Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Phosphodiesterase-5 Inhibitor Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Phosphodiesterase-5 Inhibitor Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Phosphodiesterase-5 Inhibitor Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のホスホジエステラーゼ-5阻害剤市場予測 2023年-2029年] (コード：LP23DC07604)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のホスホジエステラーゼ-5阻害剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のホスホジエステラーゼ-4阻害剤市場予測 2023年-2029年
  • 世界のセロトニン＆ノルアドレナリン再取り込み阻害薬市場予測 2023年-2029年
  • 世界の前立腺がんPARP阻害剤市場予測 2023年-2029年
  • 世界のスケール抑制剤＆防止剤市場予測 2023年-2029年
  • 世界の固体腐食防止剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆